Netherlands· NL-6ca7761254e7
Oxazepam CF 10 mg, tabletten
A oxazepam product containing oxazepam, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Oxazepam is registered in 14 of 19 countries.
Countries holding a registration under ATC N05BA04 (oxazepam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Oxazepam · ATC N05BA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of oxazepam costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.15 in France to $0.99 in Switzerland — a ×6.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Oxazepam · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.99
- FR France$0.15
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- OXAZEPAM
- Manufacturer
- Centrafarm B.V.
- Country
- Netherlands (NL)
- ATC code
- N05BA04
- ATC class
- Oxazepam
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id55928
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for oxazepam.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxazepam · interactions on record
277 records
- 4 severe
- 70 moderate
- 22 minor
- 130 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
51 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxazepam in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomOxazepam 10mg tabletsAccord-UK Ltd
- FranceOXAZEPAM ARROW 10 mg, comprimé sécableARROW GENERIQUES
- CanadaAPO-OXAZEPAMAPOTEX INC
- SwedenDelipam 10 mg Tablett2care4 Generics ApS
- NorwayDelipam2care4 Generics ApS
- PolandOxazepam EspefaChemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA
- IcelandSobrilPfizer ApS
- CzechiaOXAZEPAM LÉČIVAZentiva, k.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Anxiolit Forte, Praxiten
- Belgium · Oxazepam Eg
- Czechia · Oxazepam Léčiva
- Germany · Adumbran, Durazepam Forte
- Denmark · Oxabenz, Oxazepam Alternova
- Finland · Opamox, Oxamin
- France · Oxazepam Arrow, Oxazepam Biogaran
- United Kingdom (Northern Ireland) · Oxazepam Genus Pharmaceuticals, Oxazepam Tillomed Laboratories
- Croatia · Oksazepam Belupo, Praxiten
- Iceland · Sobril
- Italy · Serpax
- Lithuania · Nozepam, Tazepam
- Luxembourg · Oxazepam Eg
- Latvia · Nozepam, Tazepam
- Norway · Delipam, Sobril
- Poland · Oksazepam Tzf, Oxazepam Espefa
- Portugal · Serenal
- Sweden · Delipam, Oxascand
- Slovenia · Oksazepam Belupo
- Slovakia · Oxazepam Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf3bcc48-e1c9-41db-8a40-913db1341998 GET /v1/drugs/bf3bcc48-e1c9-41db-8a40-913db1341998?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h55928_smpc.pdf",
"strength": null,
"atc_label": "Oxazepam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg55928",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT"
],
"substances": [
"OXAZEPAM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h55928.pdf",
"authorised_at": "1984/04/18",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "55928",
"additional_monitoring": "N"
}See everything about oxazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.